Dataset Information


Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors.

ABSTRACT: Abnormality of fibroblast growth factor receptor (FGFR)-mediated signaling pathways were frequently found in various human malignancies, making FGFRs hot targets for cancer treatment. To address the consistent need for a new chemotype of FGFR inhibitors, here, we started with a hit structure identified from our internal hepatocyte growth factor receptor (also called c-Met) inhibitor project, and conducted a chemical optimization. After exploring three parts of the hit compound, we finally discovered a new series of pyrrolo[2,3-b]pyrazine FGFR inhibitors, which contain a novel scaffold and unique molecular shape. We believe that our findings can help others to further develop selective FGFR inhibitors.


PROVIDER: S-EPMC6154558 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6017193 | BioStudies
2020-01-01 | S-EPMC7293733 | BioStudies
2019-01-01 | S-EPMC6437634 | BioStudies
2016-01-01 | S-EPMC5019380 | BioStudies
2014-01-01 | S-EPMC4433501 | BioStudies
2017-01-01 | S-EPMC5733262 | BioStudies
2020-01-01 | S-EPMC7555921 | BioStudies
2018-01-01 | S-EPMC5925806 | BioStudies
2016-01-01 | S-EPMC6495773 | BioStudies
2019-01-01 | S-EPMC6978637 | BioStudies